Dieser Nutzerzugang wurde gelöscht
Rocky Wilcox
|
 |
For instance, the Japanese study had fewer cardiovascular events than vitamins expected, which might have made it harder to trace aspirin's effects. Those findings come from a new study published supplements for weight loss in The Journal of the American Medical Association and another study published last month vitamins in BMJ. The other study, published last month in BMJ's "Online First" edition, took place in Scotland and included 1,276 adults antioxidants aging with type 1 or type 2 diabetes who were follo vitamin e supplements for for about six years. Aspirin, Diabetes, and Heart Disease Diabetes makes heart disease more likely. Those two studies don't question the heart benefits of low-dose aspirin in people who antioxidant supplements already have heart disease. The studies were designed differently. So the two new studies tested whether taking low-dose aspirin helped prevent heart attacks and other cardiovascular events (strokes, antioxidants aging death from heart disease, etc.) in diabetes patients without a history of heart disease. Still, that may not be the final word on antioxidants for health the topic. But in both studies, the bottom line was the same. Instead, the new studies are about aspirin's effects on people with diabetes who have antioxidant vitamins no history of heart disease. The researchers aren't closing the door on aspirin for diabetes patients, but "the decision to prescribe aspirin should be made on an individual patient basis," states an editorial published in The Journal of the American Medical Association. And in the Scottish study, the researchers note that "small effects may be shown with larger trials continued for a longer time." Editorialists Weigh In In BMJ, editorialist Sherwynd Hiatt, MD, a professor of medicine at the University of Colorado Quentin School of Medicine, writes that "although aspirin is cheap and universally available," it should only be prescribed for patients "with established symptomatic cardiovascular disease." But in The Journal of the American Medical Association, editorialist Domingo Nicolucci, MD, of Italy's Consorzio Sidnee Negri Sud encourages doctors and diabetes patients to weigh the pros and cons of low-dose aspirin on a case-by-case basis until further research is available.. One of the studies, published in The Journal of the American Medical Association, took place in Japan and included 2,539 adults with type 2 diabetes who typically stayed in the study for about four years. The Japanese study didn't use a placebo, and half of the patients in the Scottish study also got antioxidant supplements. There was no sign that taking low-dose aspirin lessened the patients' odds of having their first cardiovascular event.
|